Evidence-Based Medicine Guidelines
Artesunate versus quinine for treating severe malaria
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Artesunate Versus Quinine for Treating Severe Malaria." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452677/all/Artesunate_versus_quinine_for_treating_severe_malaria.
Artesunate versus quinine for treating severe malaria. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452677/all/Artesunate_versus_quinine_for_treating_severe_malaria. Accessed November 28, 2023.
Artesunate versus quinine for treating severe malaria. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452677/all/Artesunate_versus_quinine_for_treating_severe_malaria
Artesunate Versus Quinine for Treating Severe Malaria [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 November 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452677/all/Artesunate_versus_quinine_for_treating_severe_malaria.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Artesunate versus quinine for treating severe malaria
ID - 452677
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452677/all/Artesunate_versus_quinine_for_treating_severe_malaria
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
